Bookmark and Share

Compound Summary for: CID 4585

olanzapine

Also known as: Zyprexa; 132539-06-1; Zyprexa Zydis; Olansek; Symbyax; Zalasta; Zyprexa Intramuscular; olanzapinum; Lanzac
Molecular Formula: C17H20N4S   Molecular Weight: 312.4325   InChIKey: WXPNDRBBWZMPQG-UHFFFAOYSA-N
Olanzapine is an atypical antipsychotic, approved by the FDA in 1996. Olanzapine is manufactured and marketed by the pharmaceutical company Eli Lilly and Company, whose patent for olanzapine proper ends in 2011.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Biomedical Effects and Toxicity
Safety and Handling
Environmental Fate and Exposure Potential
Exposure Standards and Regulations
Monitoring and Analysis Methods
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _